Hybio Pharmaceutical Co Ltd Sustainability Reports
Hybio Pharmaceutical Co., Ltd. focuses on the research, development, production, and sale of chemically synthesized peptide drugs, active pharmaceutical ingredients, and formulation products.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
LEI: 300300SLUTRU2A8BDP64
FIGI: BBG001V07ZD3
1 reports from 2023 to 2023
